Skip to main content
Erschienen in: Cancer Causes & Control 10/2008

01.12.2008 | Original Paper

Trends in testicular germ cell cancer incidence in Australia

verfasst von: Peter Baade, P. Carrière, L. Fritschi

Erschienen in: Cancer Causes & Control | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Although increasing incidence of testicular germ cell cancer has been reported in many developed nations, national estimates for Australia, with histological differentiation, are not currently available.

Methods

Using data from all state and territory population-based cancer registries in Australia, this paper reports on incidence trends for seminomas and non-seminomas in Australia between 1982 and 2004 using Joinpoint and Age–Period–Cohort models.

Results

Of the 10,528 testicular germ cell cancers diagnosed during this period, 6086 (58%) were seminomas. Incidence rates have increased (2.6% per year) in Australia since 1982, with the effect stronger among seminomas (3.4% per year) rather than non-seminomas (1.4% per year). There was a strong age effect evident for both subtypes, peaking in the 25–29 year age group for non-seminomas and the 30–34 year age group for seminomas. Non-seminoma rates reflected a significant birth cohort effect, following a U-shaped pattern with the lowest risk among the 1,945 birth cohort.

Conclusions

The differential trends observed for Australia for seminomas and non-seminomas are consistent with those reported for the United States, but slightly different to those reported for Europe. The trends may be at least partly due to changes over time in the prevalence of etiologic or protective factors around the time of birth.
Literatur
1.
Zurück zum Zitat Mostofi F, Sesterhenn I (2004) Tumours of the testis and paratesticular tissue. IARC Press, lyon, Contract No.: Document Number| Mostofi F, Sesterhenn I (2004) Tumours of the testis and paratesticular tissue. IARC Press, lyon, Contract No.: Document Number|
2.
Zurück zum Zitat Carrière P, Baade P, Fritschi L (2007) Population-based incidence and age distribution of spermatocytic seminoma. J Urol 178:125–128PubMedCrossRef Carrière P, Baade P, Fritschi L (2007) Population-based incidence and age distribution of spermatocytic seminoma. J Urol 178:125–128PubMedCrossRef
3.
Zurück zum Zitat Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5(3):210–222PubMedCrossRef Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5(3):210–222PubMedCrossRef
4.
Zurück zum Zitat Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA (2005) International patterns and trends of testis cancer incidence. Int J Cancer 115:822–827PubMedCrossRef Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA (2005) International patterns and trends of testis cancer incidence. Int J Cancer 115:822–827PubMedCrossRef
5.
Zurück zum Zitat McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef
6.
Zurück zum Zitat Weir HK, Marrett LD, Moravan V (1999) Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964–1996. CMAJ 160(2):201–205PubMed Weir HK, Marrett LD, Moravan V (1999) Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964–1996. CMAJ 160(2):201–205PubMed
7.
Zurück zum Zitat Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef
8.
Zurück zum Zitat Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H (2006) Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3(10):532–543PubMedCrossRef Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H (2006) Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3(10):532–543PubMedCrossRef
9.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ, Midthume DN (2000) Permutation tests for joinpoint regression with application to cancer rates. Stat Med 19:335–351PubMedCrossRef Kim HJ, Fay MP, Feuer EJ, Midthume DN (2000) Permutation tests for joinpoint regression with application to cancer rates. Stat Med 19:335–351PubMedCrossRef
11.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6(4):469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6(4):469–481PubMedCrossRef
12.
Zurück zum Zitat Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14PubMedCrossRef Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14PubMedCrossRef
13.
Zurück zum Zitat Reuter VE (2005) Origins and molecular biology of testicular germ cell tumors. Mod Pathol 18:S51–S60PubMedCrossRef Reuter VE (2005) Origins and molecular biology of testicular germ cell tumors. Mod Pathol 18:S51–S60PubMedCrossRef
14.
Zurück zum Zitat Zheng T, Holford TR, Ma Z, Ward BA, Flannery J, Boyle P (1996) Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int J Cancer 65(6):723–729PubMedCrossRef Zheng T, Holford TR, Ma Z, Ward BA, Flannery J, Boyle P (1996) Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int J Cancer 65(6):723–729PubMedCrossRef
15.
Zurück zum Zitat McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H (1999) Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162(2):361–363PubMedCrossRef McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H (1999) Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162(2):361–363PubMedCrossRef
16.
Zurück zum Zitat Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16(5):1007–1011PubMedCrossRef Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16(5):1007–1011PubMedCrossRef
17.
Zurück zum Zitat Topari J, Kaleva M, Virtanen HE (2001) Trends in the incidence of cryptorchidism and hypospadian, and methodological limitations of registry-based data. Hum Reprod Update 7(3):282–286CrossRef Topari J, Kaleva M, Virtanen HE (2001) Trends in the incidence of cryptorchidism and hypospadian, and methodological limitations of registry-based data. Hum Reprod Update 7(3):282–286CrossRef
18.
Zurück zum Zitat Virtanen HE, Rajpert-De Meyts E, Main KM, Skakkebaek NE, Toppari J (2005) Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders. Toxicol Appl Pharmacol 207(2 Suppl):501–525PubMedCrossRef Virtanen HE, Rajpert-De Meyts E, Main KM, Skakkebaek NE, Toppari J (2005) Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders. Toxicol Appl Pharmacol 207(2 Suppl):501–525PubMedCrossRef
19.
Zurück zum Zitat Sharpe RM (2003) The ‘oestrogen hypothesis’- where do we stand now?. Int J Androl 26(1):2–15PubMedCrossRef Sharpe RM (2003) The ‘oestrogen hypothesis’- where do we stand now?. Int J Androl 26(1):2–15PubMedCrossRef
20.
Zurück zum Zitat Neale RE, Carrière P, Murphy M, Baade P (2008) Testicular cancer in twins: a meta-analysis. Br J Cancer 98(1):171–173PubMedCrossRef Neale RE, Carrière P, Murphy M, Baade P (2008) Testicular cancer in twins: a meta-analysis. Br J Cancer 98(1):171–173PubMedCrossRef
21.
Zurück zum Zitat Rajpert-De Meyts E, Skakkebaek NE (1993) The possible role of sex hormones in the development of testicular cancer. Eur Urol 23:54–61PubMed Rajpert-De Meyts E, Skakkebaek NE (1993) The possible role of sex hormones in the development of testicular cancer. Eur Urol 23:54–61PubMed
22.
Zurück zum Zitat Hardell L, Van Bavel B, Lindstrom G, Carlberg M, Eriksson M, Dreifaldt AC, et al. (2004) Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. Int J Androl 27(5):282–290PubMedCrossRef Hardell L, Van Bavel B, Lindstrom G, Carlberg M, Eriksson M, Dreifaldt AC, et al. (2004) Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. Int J Androl 27(5):282–290PubMedCrossRef
23.
Zurück zum Zitat Hardell L, van Bavel B, Lindstrom G, Carlberg M, Dreifaldt AC, Wijkstrom H, et al. (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111(7):930–934PubMed Hardell L, van Bavel B, Lindstrom G, Carlberg M, Dreifaldt AC, Wijkstrom H, et al. (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111(7):930–934PubMed
24.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, et al. (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, et al. (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef
25.
Zurück zum Zitat Aalen OO, Tretli S (1999) Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 10:285–292PubMedCrossRef Aalen OO, Tretli S (1999) Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 10:285–292PubMedCrossRef
26.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef
Metadaten
Titel
Trends in testicular germ cell cancer incidence in Australia
verfasst von
Peter Baade
P. Carrière
L. Fritschi
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9168-z

Weitere Artikel der Ausgabe 10/2008

Cancer Causes & Control 10/2008 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.